Chemoinformatics Market Share, Sourcing Strategy and Downstream Buyers 2021-2024
The global Chemoinformatics Market size is expected to value at USD 21.18 billion by 2024. The market is subject to witness a substantial growth due to the growing prevalence of chronic diseases and increasing investment by private bodies in development of novel drugs. In addition, rising importance towards development of various drug validation techniques, and integration of potential drug candidates that are developed by combinatorial chemical methods, are expected to stimulate the growth of chemoinformatics industry over the forecast period.
Shifting focus towards
the effective management of data, gathered during molecular and atomic
reactions is anticipated to boost market demand for chemoinformatics over the
next seven years. Globally, the chemoinformatics market is predicted to grow at
higher CAGR in the forecast period, providing numerous opportunities for market
players to invest for research and development in the market.
Request a Sample Copy
of Chemoinformatics Market Report @ https://www.millioninsights.com/industry-reports/chemoinformatics-market/request-sample
The recent
technological advances in computer technology for healthcare sector is
estimated to favor the growth of chemoinformatics industry in the upcoming
years. Some of the key contributing factors responsible for sustained market
growth of chemoinformatics include surging prevalence of chronic diseases and
the corresponding need to invent novel drugs. The rising awareness levels among
general population in regards to the importance of personalized medicine is
expected to drive the demand for effective medication, thus impelling market
growth as well. Moreover, the rising number of incidences related to chronic
diseases acts as a contributing factor for new drug development, which is
directly impacting the market growth of the chemoinformatics.
The chemoinformatics market is broadly categorized into three major
segments based on the application type such as
chemical analysis, drug discovery, and drug validation. The drug discovery is
considered as one of the fastest growing segment in the chemoinformatics
industry with substantial revenue generation in the last few years. Growing
popularity of the drug discovery segment is attributed to the rise in the
number of research & development activities, particularly in the North
America region. The drug validation segment has also witnessed substantial
growth owing to the higher approval rate by international & local
authorities.
The key players in the chemoinformatics industry are BIOVIA
(formerly Accelrys) Co., ACD/Labs, Inc., Agilent Technologies, Inc., Cambridgesoft
Co., ChemAxon, Inc., Bio-Rad Laboratories, Inc., Schrödinger, LLC, and
Molecular Discovery Ltd.
The chemoinformatics market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine & pharmaceutical sector, increase in the number of research & development activities, and existence of well-established healthcare infrastructure in the region. Asia-Pacific region is predicted to hold major market share in the chemoinformatics with massive growth in forecast period.
Access Chemoinformatics
Market Report with TOC @ https://www.millioninsights.com/industry-reports/chemoinformatics-market
Table of Contents
Chapter 1 Executive
Summary
Chapter 2 Market Snapshot
Chapter 3 Market
Variables, Trends & Scope
Chapter 4
Market Categorization 1: Applications Estimates & Trend Analysis
Chapter 5
Market Categorization 3: Regional Estimates & Trend Analysis, by Product
& Application
Chapter 6
Competitive Landscape
Comments
Post a Comment